Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Known antidiabetic agent modulates glucocorticoid response in osteoclasts

Sep. 18, 1997

Role of osteoprotegerin in skeletal metabolism elucidated

Sep. 18, 1997

Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats

Sep. 18, 1997

Growth hormone antagonist enters phase II

Sep. 18, 1997

Duke University granted orphan drug status for Pompe's disease therapy

Sep. 17, 1997

Role of IL-1 receptors in osteoporosis elucidated

Sep. 17, 1997

Highlights from the Japanese Society of Bone Metabolism Research

Sep. 17, 1997

Fenfluramine, dexfenfluramine voluntarily withdrawn

Sep. 16, 1997

Hormone therapy vs. simvastatin for hypercholesterolemia in postmenopausal women

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...